Creation of a recombinant Rift Valley fever virus with a two-segmented genome.
about
RNA Encapsidation and Packaging in the PhlebovirusesIn memoriam--Richard M. Elliott (1954-2015)Novel approaches to develop Rift Valley fever vaccinesReassortment between two serologically unrelated bluetongue virus strains is flexible and can involve any genome segmentBiochemical and biophysical characterization of cell-free synthesized Rift Valley fever virus nucleoprotein capsids enables in vitro screening to identify novel antivirals.Rift Valley fever virus incorporates the 78 kDa glycoprotein into virions matured in mosquito C6/36 cells.Mapping of transcription termination within the S segment of SFTS phlebovirus facilitated the generation of NSs-deletant viruses.Creation of Rift Valley fever viruses with four-segmented genomes reveals flexibility in bunyavirus genome packagingThe consequences of reconfiguring the ambisense S genome segment of Rift Valley fever virus on viral replication in mammalian and mosquito cells and for genome packaging.Inhibitors of the interferon response enhance virus replication in vitro.Flexibility of bunyavirus genomes: creation of an orthobunyavirus with an ambisense S segment.Single-Molecule FISH Reveals Non-selective Packaging of Rift Valley Fever Virus Genome Segments.Serum levels of inflammatory cytokines in Rift Valley fever patients are indicative of severe diseaseNovel vaccine strategies against emerging viruses.Establishment of a reverse genetics system for Schmallenberg virus, a newly emerged orthobunyavirus in Europe.Roles of the coding and noncoding regions of rift valley Fever virus RNA genome segments in viral RNA packagingMutational analysis of Rift Valley fever phlebovirus nucleocapsid protein indicates novel conserved, functional amino acids.
P2860
Q26314415-EFB95490-C4F7-495D-848D-2AA6152468F0Q26700157-A7D8D463-43E6-4497-A023-0B350283D5A2Q27027003-A3961267-039E-4AC5-9045-A9F87977BA99Q28392676-3B27103D-69BE-4EB1-9DB7-62C95D31CA6DQ30152032-AC4845C2-F93C-408A-AC64-D1F486CA8847Q31149260-EC06B034-FF81-4546-B1E6-4D779CB74893Q33442499-74EA5B6F-1C4D-49BC-90D9-503A0B9CDC94Q34262159-E1946CF2-EFB2-4318-87EA-F49DD5A794D2Q35097103-05B3B322-9AF6-463D-8F2E-525B502418ABQ35414495-69B5BAA5-CC45-4EB6-9866-272F3CAAC4FCQ35641541-C3090745-78DA-4FC4-AC67-FE1C99DFA838Q36109044-A58F6CF2-B591-4F79-9FB0-40C80016C164Q36127490-157D0227-07A7-419B-816C-BC124C719507Q36816140-6AFE8AB6-493F-4D0B-9AFF-D36342260CBCQ39223078-E2DEA95A-BF70-4603-8CC5-57F4DEFD13A0Q39406139-6B26C29E-777B-4343-955B-55A5A7047732Q47265320-4D4FFB6E-D402-4883-A3F1-F215E5469320
P2860
Creation of a recombinant Rift Valley fever virus with a two-segmented genome.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Creation of a recombinant Rift Valley fever virus with a two-segmented genome.
@en
type
label
Creation of a recombinant Rift Valley fever virus with a two-segmented genome.
@en
prefLabel
Creation of a recombinant Rift Valley fever virus with a two-segmented genome.
@en
P2860
P356
P1433
P1476
Creation of a recombinant Rift Valley fever virus with a two-segmented genome.
@en
P2093
Angela McLees
Richard M Elliott
P2860
P304
10310-10318
P356
10.1128/JVI.05252-11
P407
P577
2011-07-27T00:00:00Z